Polyneuropathies  >>  AZD 2423  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AZD 2423 / AstraZeneca
NCT01201317: A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy

Completed
2
134
US, Canada
AZD2423, Placebo
AstraZeneca
Neuropathic Pain
06/11
06/11

Download Options